Yüklüyor......
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...
Kaydedildi:
| Yayımlandı: | Oxid Med Cell Longev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6874879/ https://ncbi.nlm.nih.gov/pubmed/31781355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8730816 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|